Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Multiple-stage, Double-blind, Randomized, Placebo-controlled, Two-way Crossover, Single-dose Study to Investigate the Effects of ACT-078573 on Sleep Measured by Polysomnography in Patients With Primary Insomnia

NCT00640848 is registered in ClinicalTrials.gov with Midnight Pharma, LLC as lead sponsor.

NCT NCT00640848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00640848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Multiple-stage, Double-blind, Randomized, Placebo-controlled, Two-way Crossover, Single-dose Study to Investigate the Effects of ACT-078573 on Sleep Measured by Polysomnography in Patients With Primary Insomnia
Lead sponsor
Midnight Pharma, LLC
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2006
Completion date
September 30, 2007
Enrollment
161 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia, primary insomnia